Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HIG | Stock Option | Options Exercise | $0 | -46.8K | -31.75% | $0.00 | 101K | Jan 19, 2024 | Common Stock | 46.8K | $41.25 | Direct | F5 |
transaction | HIG | Stock Option | Options Exercise | $0 | -956 | -0.95% | $0.00 | 99.7K | Jan 22, 2024 | Common Stock | 956 | $41.25 | Direct | F5 |
holding | HIG | Stock Option | 294K | Jan 19, 2024 | Common Stock | 294K | $43.59 | Direct | F6 | |||||
holding | HIG | Stock Option | 303K | Jan 19, 2024 | Common Stock | 303K | $48.89 | Direct | F7 | |||||
holding | HIG | Stock Option | 352K | Jan 19, 2024 | Common Stock | 352K | $49.01 | Direct | F8 | |||||
holding | HIG | Stock Option | 311K | Jan 19, 2024 | Common Stock | 311K | $51.87 | Direct | F9 | |||||
holding | HIG | Stock Option | 285K | Jan 19, 2024 | Common Stock | 285K | $53.81 | Direct | F10 | |||||
holding | HIG | Stock Option | 328K | Jan 19, 2024 | Common Stock | 328K | $55.27 | Direct | F11 | |||||
holding | HIG | Stock Option | 302K | Jan 19, 2024 | Common Stock | 302K | $69.41 | Direct | F12 | |||||
holding | HIG | Stock Option | 249K | Jan 19, 2024 | Common Stock | 249K | $78.28 | Direct | F13 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on September 15, 2023, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2015 and scheduled to expire on March 3, 2025. |
F2 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $84.99 - $85.11 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F3 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $83.99 - $84.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F4 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $86.00 - $86.01 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F5 | The options became fully exercisable on March 3, 2018, the third anniversary of the grant date. |
F6 | The options became fully exercisable on March 1, 2019, the third anniversary of the grant date. |
F7 | The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. |
F8 | The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. |
F9 | One-third of the options became exercisable on February 23, 2022, an additional one-third of the options became exercisable on February 23, 2023 and the remaining one-third of the options will become exercisable on February 23, 2024, the third anniversary of the grant date. |
F10 | The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. |
F11 | The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. |
F12 | One-third of the options became exercisable on February 23, 2023, an additional one-third of the options will become exercisable on February 23, 2024 and the remaining one-third of the options will become exercisable on February 23, 2025, the third anniversary of the grant date. |
F13 | One-third of the options will become exercisable on February 28, 2024, an additional one-third of the options will become exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. |